PLANNING RESEARCH AND DEVELOPMENT OF NEW DRUGS TO ASSURE REGULATORY APPROVAL

被引：0
|
作者：
HURLEY, FL
机构：
来源：
FOOD AND DRUG LAW JOURNAL | 1984年 / 39卷 / 03期
关键词：
D O I：
暂无
中图分类号：
TS2 [食品工业];
学科分类号：
0832 ;
摘要：
引用
收藏
页码：312 / 317
页数：6
相关论文
共 50 条
  • [21] Development of new drugs from an FDA regulatory perspective
    不详
    CLINICAL BIOCHEMISTRY, 2004, 37 (12) : 1126 - 1126
  • [22] Verifying Clinical Benefit of New Anticancer Drugs After Regulatory Approval Based on Exploratory Studies
    Ito, Akira
    Narukawa, Mamoru
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2025,
  • [23] The path to approval of new drugs for diabetes
    Rendell, Marc
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (02) : 195 - 207
  • [24] APPROVAL OF NEW DRUGS IN SOVIET UNION
    PERSHIN, GN
    BIOCHEMICAL PHARMACOLOGY, 1963, 12 : 91 - &
  • [25] The hazards of rapid approval of new drugs
    Martin, Jennifer
    Shenfield, Gillian
    AUSTRALIAN PRESCRIBER, 2016, 39 (01) : 2 - 3
  • [26] Comparing approval procedures for new drugs
    Houy, Nicolas
    Jelovac, Izabela
    WORLD ECONOMY, 2019, 42 (05): : 1598 - 1619
  • [27] EVIDENCE USED FOR APPROVAL OF NEW DRUGS
    BOTSTEIN, P
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1986, 22 (3-4): : 197 - 200
  • [28] Approval of new drugs in Brazil.
    Passos, Patricia Martins
    Passos, Patricia Martins
    Simoes Travassos Soares, Marcos Coelho
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] The Regulation and Approval of New Drugs in China
    Rongling Deng
    Kenneth I Kaitin
    Drug information journal : DIJ / Drug Information Association, 2004, 38 (1): : 29 - 39
  • [30] The regulation and approval of new drugs in China
    Deng, RL
    Kaitin, KI
    DRUG INFORMATION JOURNAL, 2004, 38 (01): : 29 - 39
12345